Methods and compositions for treating neuropathic and neurodegenerative conditions

Details for Australian Patent Application No. 2005232665 (hide)

Owner Sangamo BioSciences, Inc.

Inventors Martin, J. Tyler

Agent Wrays

Pub. Number AU-B-2005232665

PCT Pub. Number WO2005/099771

Priority 60/560,566 08.04.04 US; 60/631,455 29.11.04 US

Filing date 7 April 2005

Wipo publication date 27 October 2005

Acceptance publication date 13 May 2010

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/099771 Priority application(s): WO2005/099771

13 May 2010 Application Accepted

  Published as AU-B-2005232665

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232671-Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability

2005232657-ErbB antagonists for pain therapy